Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 11 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Hormones Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Estramustine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1996 2022

Research Output 1985 2016

  • 10691 Citations
  • 40 Scopus h-Index
  • 104 Article
  • 14 Review article
  • 4 Comment/debate

A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy

Jackson, W. C., Feng, F. Y., Daignault, S., Hussain, M., Smith, D., Cooney, K., Pienta, K., Jolly, S., Hollenbeck, B., Olson, K. B., Sandler, H. M., Ray, M. E. & Hamstra, D. A. Jan 1 2016 In : Advances in Radiation Oncology. 1, 1, p. 59-66 8 p.

Research output: Contribution to journalArticle

Salvage Therapy
Prostate-Specific Antigen
Prostatectomy
Radiation
Neutropenia

Electrocardiographic characterization of ramucirumab on the corrected qt interval in a phase ii study of patients with advanced solid tumors

Olszanski, A. J., Smith, D. C., Camacho, L. H., Thompson, J., Ramalingam, S. S., Donald Harvey, R., Campos, L., Ferry, D., Tang, S., Gao, L. & Safran, H. Apr 1 2016 In : Oncologist. 21, 4, p. 402-403 2 p.

Research output: Contribution to journalArticle

Neoplasms
Vascular Endothelial Growth Factor Receptor-2
Least-Squares Analysis
Non-Small Cell Lung Carcinoma
Immunoglobulins

Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors

Smith, D. C., Powderly, J., Lee, J. J., Shepard, D. R., Wallin, J., Chaudhary, A., Chao, G. Y., Ng, W. T., Mitchell, M. I., Grau, G., Kurek, R. & LoRusso, P. Aug 1 2016 In : Cancer Chemotherapy and Pharmacology. 78, 2, p. 271-280 10 p.

Research output: Contribution to journalArticle

Neoplasms
Safety
Epidermal Growth Factor Receptor
Immunoglobulins
Electrocardiography
3 Citations

First-in-human multicenter phase i study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70

Owonikoko, T. K., Hussain, A., Stadler, W. M., Smith, D. C., Kluger, H., Molina, A. M., Gulati, P., Shah, A., Ahlers, C. M., Cardarelli, P. M. & Cohen, L. J. Jan 1 2016 In : Cancer Chemotherapy and Pharmacology. 77, 1, p. 155-162 8 p.

Research output: Contribution to journalArticle

Drug Delivery Systems
Antibodies
Pharmacokinetics
Pericardial Effusion
Appetite
1 Citations

Lack of pharmacokinetic drug–drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors

Chow, L. Q. M., Smith, D. C., Tan, A. R., Denlinger, C. S., Wang, D., Shepard, D. R., Chaudhary, A., Lin, Y. & Gao, L. Aug 1 2016 In : Cancer Chemotherapy and Pharmacology. 78, 2, p. 433-441 9 p.

Research output: Contribution to journalArticle

Paclitaxel
Drug Interactions
Pharmacokinetics
Neoplasms
Confidence Intervals